POPULARITY
48 episodes with prostate cancer patient conference
49 episodes with prostate cancer patient conference
49 episodes with prostate cancer patient conference
45 episodes with prostate cancer patient conference
19 episodes with prostate cancer patient conference
49 episodes with prostate cancer patient conference
19 episodes with prostate cancer patient conference
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39768]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39768]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39768]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39768]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small discusses systemic therapy treatment in advanced prostate cancer, including AR-targeted therapy. The presentation includes definitions of disease states, categories of treatment types, and standards in treatment selection. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39768]
As part of the 2024 Prostate Cancer Patient Conference, Dr. David Oh presents on the use of immunotherapy as a treatment in advanced prostate cancer, including describing how immunotherapy works, possible side effects, and options available currently. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39770]
As part of the 2024 Prostate Cancer Patient Conference, Dr. David Oh presents on the use of immunotherapy as a treatment in advanced prostate cancer, including describing how immunotherapy works, possible side effects, and options available currently. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39770]
As part of the 2024 Prostate Cancer Patient Conference, Dr. David Oh presents on the use of immunotherapy as a treatment in advanced prostate cancer, including describing how immunotherapy works, possible side effects, and options available currently. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39770]
As part of the 2024 Prostate Cancer Patient Conference, Dr. David Oh presents on the use of immunotherapy as a treatment in advanced prostate cancer, including describing how immunotherapy works, possible side effects, and options available currently. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39770]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Matthew Cooperberg discusses surgery as treatment for localized prostate cancer, including risk stratification, how prostatectomy is performed, surgery outcomes and potential side effects. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39758]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Matthew Cooperberg discusses surgery as treatment for localized prostate cancer, including risk stratification, how prostatectomy is performed, surgery outcomes and potential side effects. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39758]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Matthew Cooperberg discusses surgery as treatment for localized prostate cancer, including risk stratification, how prostatectomy is performed, surgery outcomes and potential side effects. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39758]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Matthew Cooperberg discusses surgery as treatment for localized prostate cancer, including risk stratification, how prostatectomy is performed, surgery outcomes and potential side effects. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39758]
As part of the 2024 Prostate Cancer Patient Conference, Drs. Julian Hong and Eric Small discuss oligometastatic prostate cancer and its management with radiation and systemic therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39766]
As part of the 2024 Prostate Cancer Patient Conference, Drs. Julian Hong and Eric Small discuss oligometastatic prostate cancer and its management with radiation and systemic therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39766]
As part of the 2024 Prostate Cancer Patient Conference, Drs. Julian Hong and Eric Small discuss oligometastatic prostate cancer and its management with radiation and systemic therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39766]
As part of the 2024 Prostate Cancer Patient Conference, Drs. Julian Hong and Eric Small discuss oligometastatic prostate cancer and its management with radiation and systemic therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39766]
As part of the 2024 Prostate Cancer Patient Conference, patient advocate Stan Rosenfeld leads a panel discussion including Dr. Benjamin Breyer, patients, and their partners, on living with prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39773]
As part of the 2024 Prostate Cancer Patient Conference, patient advocate Stan Rosenfeld leads a panel discussion including Dr. Benjamin Breyer, patients, and their partners, on living with prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39773]
As part of the 2024 Prostate Cancer Patient Conference, patient advocate Stan Rosenfeld leads a panel discussion including Dr. Benjamin Breyer, patients, and their partners, on living with prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39773]
As part of the 2024 Prostate Cancer Patient Conference, patient advocate Stan Rosenfeld leads a panel discussion including Dr. Benjamin Breyer, patients, and their partners, on living with prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39773]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Rahul Aggarwal reviews emerging treatment approaches for advanced prostate cancer, including developments for antibody-drug conjugates, immunotherapy (T cell engagers), targeted radiation, and targeting Androgen Receptor Signaling. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39772]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Rahul Aggarwal reviews emerging treatment approaches for advanced prostate cancer, including developments for antibody-drug conjugates, immunotherapy (T cell engagers), targeted radiation, and targeting Androgen Receptor Signaling. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39772]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Rahul Aggarwal reviews emerging treatment approaches for advanced prostate cancer, including developments for antibody-drug conjugates, immunotherapy (T cell engagers), targeted radiation, and targeting Androgen Receptor Signaling. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39772]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Rahul Aggarwal reviews emerging treatment approaches for advanced prostate cancer, including developments for antibody-drug conjugates, immunotherapy (T cell engagers), targeted radiation, and targeting Androgen Receptor Signaling. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39772]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Thomas Hope presents information on PSMA-PET and discusses imaging in the evaluation of biochemical recurrence in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39762]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Thomas Hope presents information on PSMA-PET and discusses imaging in the evaluation of biochemical recurrence in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39762]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Thomas Hope presents information on PSMA-PET and discusses imaging in the evaluation of biochemical recurrence in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39762]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Thomas Hope presents information on PSMA-PET and discusses imaging in the evaluation of biochemical recurrence in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39762]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Terence Friedlander discusses bone health in advanced prostate cancer. He reviews normal bone health and how it is affected by prostate cancer, defines important terms, and shares recommendations for optimizing bone health in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39771]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Terence Friedlander discusses bone health in advanced prostate cancer. He reviews normal bone health and how it is affected by prostate cancer, defines important terms, and shares recommendations for optimizing bone health in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39771]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Terence Friedlander discusses bone health in advanced prostate cancer. He reviews normal bone health and how it is affected by prostate cancer, defines important terms, and shares recommendations for optimizing bone health in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39771]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Terence Friedlander discusses bone health in advanced prostate cancer. He reviews normal bone health and how it is affected by prostate cancer, defines important terms, and shares recommendations for optimizing bone health in prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39771]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Hao Nguyen discusses focal therapy as a choice of therapy in patients with low and intermediate risk prostate cancer at high risk for progression. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39760]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Hao Nguyen discusses focal therapy as a choice of therapy in patients with low and intermediate risk prostate cancer at high risk for progression. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39760]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Hao Nguyen discusses focal therapy as a choice of therapy in patients with low and intermediate risk prostate cancer at high risk for progression. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39760]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Hao Nguyen discusses focal therapy as a choice of therapy in patients with low and intermediate risk prostate cancer at high risk for progression. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39760]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39756]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39756]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39756]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39756]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Julian Hong discusses radiation therapy as treatment for prostate cancer, including potential side effects, considerations in decision making, the radiation oncology care path. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39759]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Julian Hong discusses radiation therapy as treatment for prostate cancer, including potential side effects, considerations in decision making, the radiation oncology care path. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39759]
As part of the 2024 Prostate Cancer Patient Conference, Drs. June Chan and Stacey Kenfield present recommendations for diet and exercise based in research with prostate cancer patients. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39767]
As part of the 2024 Prostate Cancer Patient Conference, Drs. June Chan and Stacey Kenfield present recommendations for diet and exercise based in research with prostate cancer patients. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39767]
As part of the 2024 Prostate Cancer Patient Conference, Dr. Ivan de Kouchkovksky discusses the use of both chemotherapy and radioligand therapy, including a “theranostic” approach, in metastatic treatment resistant prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39769]
© 2020-2025 Ivy Podcast Discovery LLC
